Overview

Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate and response duration with the combination of eltrombopag and high-dose dexamethasone
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate